GSK announces additional purchase agreements with the Government of Canada for COVID-19 monoclonal antibody therapy, Sotrovimab
MISSISSAUGA, ON, Jan. 6, 2022 /CNW/ – GSK today announced it has signed agreements with the Government of Canada to supply 20,000 doses of Sotrovimab for...

